OpenVSafe by OpenVAERS
Search V-safe

75Y-11710-69582

3 vaccinations 3 coded responses 17 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
875 / NM
Registered
2020-12-16
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2020-12-16
    Registered in v-safe
  2. 2020-12-16
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-16
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-25
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2020-12-30
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-13
    Dose 2 — Pfizer-BioNTech
  12. 2021-03-17
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-06-16
    Health check-in — 6 months, dose 1
    Feeling: Fair
    Adult check-in
  14. 2021-07-14
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-10-13
    Dose 3 — Pfizer-BioNTech
  16. 2021-11-14
    Survey response — day 28, dose 3
    MedDRA: Dyspnoea, Palpitations, Vertigo — Feeling: Fair
    Free text: Shortness of breath heart palpitations vertigo
    MedDRA releases: 2024-11 · check-in free text available
  17. 2021-11-17
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  18. 2021-11-24
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  19. 2022-01-12
    Survey response — 3 months, dose 3
    MedDRA: Supraventricular extrasystoles — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Premature atrial contractions.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-01-12
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · 1 call case(s)
  21. 2022-04-15
    Survey response — 6 months, dose 3
    MedDRA: Palpitations — Feeling: Good
    Free text: Heart palpitations
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-04-29
  23. 2022-10-13
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-16Pfizer-BioNTech
22021-01-13Pfizer-BioNTech
32021-10-13Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-01-12 Unsuccessful

Free text

Release 10 — day 28, dose 3

2021-11-14

Symptoms: Shortness of breath heart palpitations vertigo

Release 10 — 3 months, dose 3

2022-01-12

Symptoms: Premature atrial contractions.

Release 11 — 6 months, dose 3

2022-04-15

Symptoms: Heart palpitations

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDyspnoea · · ✓
SDPalpitations · · ✓
SDSupraventricular extrasystoles · · ✓
SDVertigo · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release